Non-small cell lung cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who underwent complete resection for < 3cm adenocarcinoma, squamous cell carcinoma, and adenosquamous cell carcinoma between April 2018 and March 2024.
Exclusion criteria
Exclusion criteria: Patients receiving induction therapy, underwent combined resection of chest wall, pathologically confirmed lymph node metastasis, intrapulmonary metastasis, or interlobular pl3, presence of multiple lung cancers, or margin distance unreported.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Freedom from the loco-regional recurrence | — |
Secondary
| Measure | Time frame |
|---|---|
| cumulative incidence of loco-regional recurrence | — |
Countries
Japan
Contacts
Hyogo Cancer Center Division of chest surgery